Cleveland Clinic Innovations helps turn medical breakthrough inventions into products and companies. Since it was created in 2000, CCI has issued over 850 patents and executed more than 500 licenses on medical devices and techniques. The new department within CCI, Cleveland Clinic Ventures, will help raise funds to get innovative ideas to market and to maximize the performance of spinoff companies.
Brian Donley, MD, Cleveland Clinic’s chief of staff, told Becker’s CCV will assist the spinoff companies with funding strategies, business model development and technology road maps.
“This new structure will position us to have an even more robust, streamlined commercialization impact and successfully fulfill our potential as a world-class destination for healthcare commercialization,” says Dr. Donley. “Cleveland Clinic Innovations and Cleveland Clinic Ventures work together seamlessly, sharing expertise, with a relentless focus on advancing technologies to improve patient care for Cleveland Clinic patients, and other patients locally, nationally and internationally.”
Cleveland Clinic recently appointed new leaders for both entities. Peter O’Neill was named executive director of Cleveland Clinic Innovations and Jack Miner was appointed managing director of Cleveland Clinic Ventures.
More articles on technology and innovation:
3 things C-suite leaders should know before adopting blockchain
How healthcare organizations can embrace mobile technology
Intermedix acquires WPC Healthcare to add data science capabilities
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
